A breast cancer patient-derived xenograft and organoid platform for drug discovery and precision oncology
Katrin P. Guillen(University of Utah), Alana L. Welm(Huntsman Cancer Institute)
Cited by 20
Related Papers
Dll1-Mediated Notch Signaling Drives Tumor Cell Cross-talk with Cancer-Associated Fibroblasts to Promote Radioresistance in Breast Cancer
|Cancer Research|2022|37
Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approach
|iScience|2022|35
mTORC1 is a key mediator of RON-dependent breast cancer metastasis with therapeutic potential
|npj Breast Cancer|2018|21
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer
|Cancer Research|2023|15
The importance of developing therapies targeting the biological spectrum of metastatic disease
|Clinical & Experimental Metastasis|2019|13